1.Carboni L, El Khoury A, Beiderbeck DI, Neumann ID, Mathé AA. Neuropeptide Y, calcitonin gene-related peptide, and neurokinin A in brain regions of HAB rats correlate with anxiety-like behaviours. Eur Neuropsychopharmacol. 2022; 57:1-14. doi: 10.1016/j.euroneuro.2021.12.011.
2.Formaggio F, Rimondini R, Delprete C, Scalia L, Merlo Pich E, Liguori R, Nicoletti F, Caprini M. L-Acetylcarnitine causes analgesia in mice modeling Fabry disease by up-regulating type-2 metabotropic glutamate receptors. Mol Pain. 2022; 18:17448069221087033. doi: 10.1177/17448069221087033.
3.Carboni L, Ponzoni L, Braida D, Sala M, Gotti C, Zoli M. Altered mRNA Levels of Stress-Related Peptides in Mouse Hippocampus and Caudate-Putamen in Withdrawal after Long-Term Intermittent Exposure to Tobacco Smoke or Electronic Cigarette Vapour. Int J Mol Sci. 2021; 22:599. doi: 10.3390/ijms22020599.
4.Vignoli B, Sansevero G, Sasi M, Rimondini R, Blum R, Bonaldo V, Biasini E, Santi S, Berardi N, Lu B, Canossa M. Astrocytic microdomains from mouse cortex gain molecular control over long-term information storage and memory retention. Commun Biol. 2021; 4:1152. doi: 10.1038/s42003-021-02678-x.
5.Carboni L, McCarthy DJ, Delafont B, Filosi M, Ivanchenko E, Ratti E, Learned SM, Alexander R, Domenici E. Biomarkers for response in major depression: comparing paroxetine and venlafaxine from two randomised placebo-controlled clinical studies. Transl Psychiatry. 2019; 9:182. doi: 10.1038/s41398-019-0521-7.
6.Caberlotto L, Nguyen TP, Lauria M, Priami C, Rimondini R, Maioli S, Cedazo-Minguez A, Sita G, Morroni F, Corsi M, Carboni L. Cross-disease analysis of Alzheimer's disease and type-2 Diabetes highlights the role of autophagy in the pathophysiology of two highly comorbid diseases. Sci Rep. 2019; 9:3965. doi: 10.1038/s41598-019-39828-5.
7.Carboni L, Marchetti L, Lauria M, Gass P, Vollmayr B, Redfern A, Jones L, Razzoli M, Malki K, Begni V, Riva MA, Domenici E, Caberlotto L, Mathé AA. Cross-species evidence from human and rat brain transcriptome for growth factor signaling pathway dysregulation in major depression. Neuropsychopharmacology. 2018; 43:2134-2145. doi: 10.1038/s41386-018-0117-6.
8.Koch G, Di Lorenzo F, Loizzo S, Motta C, Travaglione S, Baiula M, Rimondini R, Ponzo V, Bonnì S, Toniolo S, Sallustio F, Bozzali M, Caltagirone C, Campana G, Martorana A. CSF tau is associated with impaired cortical plasticity, cognitive decline and astrocyte survival only in APOE4-positive Alzheimer's disease. Sci Rep. 2017; 7:13728. doi: 10.1038/s41598-017-14204-3.
9.Persson T, Lattanzio F, Calvo-Garrido J, Rimondini R, Rubio-Rodrigo M, Sundström E, Maioli S, Sandebring-Matton A, Cedazo-Mínguez Á. Apolipoprotein E4 Elicits Lysosomal Cathepsin D Release, Decreased Thioredoxin-1 Levels, and Apoptosis. J Alzheimers Dis. 2017; 56:601-617. doi: 10.3233/JAD-150738.
10.Carboni L, Negri M, Michielin F, Bertani S, Fratte SD, Oliosi B, Cavanni P. Slow dissociation of partial agonists from the D₂ receptor is linked to reduced prolactin release. Int J Neuropsychopharmacol. 2012 15:645-56. doi: 10.1017/S1461145711000824.
